Cachexia Market Value Share, Supply Demand, share 2016 2026
The report Cachexia Market focuses on major leading Market players, Key market segments and sub-segments to provide comprehensive and insightful data
(EMAILWIRE.COM, January 26, 2018 ) According to the most recent consensus statement (Muscaritoli et al 2010), cachexia can be defined as weight loss exceeding 5% within the previous 3-12 months in patients with long term chronic conditions OR BMI < 20 kg/m², combined with symptoms characteristic for cachexia, loss of skeletal muscle and biochemical abnormalities. While the same mechanisms that contribute to sarcopenia undoubtedly contribute to cachexia, in addition there are specific mechanisms that contribute to muscle wasting from an underlying pathology. These include: inflammation, in particular IL-6, IL-1 and TNF-α, and irregular protein metabolism. Patients with cachexia tend to burn more energy during their resting state than sarcopenic patients.
Explore More Information about report @ https://www.researchcosmos.com/reports/cachexia-in-8-major-markets-forecast-report-2016-2026/1542051178
This report provides the current prevalent population Cachexia across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Request free sample @ https://www.researchcosmos.com/request/1542051178
Providing a value-added level of insight from the analysis team , several of the main symptoms and co-morbidities of Cachexia have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Inquire before buying @ https://www.researchcosmos.com/inquire/1542051178
Key underlying pathologies linked with developing cachexia include:
COPD
CKD and end stage renal disease (ESRD)
CHF
Cancer
AIDS and HIV
Rheumatoid arthritis and other autoimmune conditions
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
Able to quantify patient populations in the global Cachexia market to target the development of future products, pricing strategies and launch plans.
Gain further insight into the prevalence of the subdivided types of Cachexia and identify patient segments with high potential.
Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
Provide a level of understanding on the impact from specific co-morbid conditions on Cachexias prevalent population.
Identify sub-populations within Cachexia which require treatment.
Gain an understanding of the specific markets that have the largest number of Cachexia patients.
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. Were associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Explore More Information about report @ https://www.researchcosmos.com/reports/cachexia-in-8-major-markets-forecast-report-2016-2026/1542051178
This report provides the current prevalent population Cachexia across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Request free sample @ https://www.researchcosmos.com/request/1542051178
Providing a value-added level of insight from the analysis team , several of the main symptoms and co-morbidities of Cachexia have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Inquire before buying @ https://www.researchcosmos.com/inquire/1542051178
Key underlying pathologies linked with developing cachexia include:
COPD
CKD and end stage renal disease (ESRD)
CHF
Cancer
AIDS and HIV
Rheumatoid arthritis and other autoimmune conditions
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
Able to quantify patient populations in the global Cachexia market to target the development of future products, pricing strategies and launch plans.
Gain further insight into the prevalence of the subdivided types of Cachexia and identify patient segments with high potential.
Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
Provide a level of understanding on the impact from specific co-morbid conditions on Cachexias prevalent population.
Identify sub-populations within Cachexia which require treatment.
Gain an understanding of the specific markets that have the largest number of Cachexia patients.
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. Were associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Information:
Research Cosmos
Dani Rodriguez
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research Cosmos
Dani Rodriguez
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results